Novoprotein(SH:688137) Xin Lang Cai Jing·2025-12-19 03:42Group 1 - The stock price of Nearshore Protein increased by 5.23% to 41.68 CNY per share, with a trading volume of 16.58 million CNY and a turnover rate of 1.26%, resulting in a total market capitalization of 2.925 billion CNY [1] - Suzhou Nearshore Protein Technology Co., Ltd. was established on September 7, 2009, and went public on September 29, 2022. The company specializes in the research, development, production, and sales of target and factor proteins, recombinant antibodies, enzymes, and reagents, along with providing related technical services [1] - The revenue composition of the company's main business includes: target and factor proteins (58.04%), enzymes and reagents (25.63%), CRO services (11.87%), recombinant antibodies (2.67%), and other (1.79%) [1] Group 2 - According to data from the top ten holdings of funds, one fund under China Merchants Fund holds a significant position in Nearshore Protein. The fund, China Merchants Anze Stable Profit 9-Month Holding Period Mixed A (019698), held 156,100 shares in the third quarter, accounting for 0.8% of the fund's net value, making it the fourth-largest holding [2] - The fund has a current scale of 516 million CNY and has achieved a return of 11.05% this year, ranking 5426 out of 8098 in its category. Over the past year, it has returned 10.29%, ranking 5409 out of 8067, and since its inception, it has returned 20.01% [2] Group 3 - The fund managers of China Merchants Anze Stable Profit 9-Month Holding Period Mixed A are Teng Yue and Wang Juanjuan. Teng Yue has a tenure of 8 years and 286 days, managing assets totaling 24.98 billion CNY, with the best fund return during his tenure being 51.01% and the worst being -3.32% [3] - Wang Juanjuan has a tenure of 3 years and 355 days, managing assets totaling 28.123 billion CNY, with the best fund return during her tenure being 22.78% and the worst being 1.23% [3]